08:00 , Feb 20, 2012 |  BC Week In Review  |  Clinical News

GeneChip System 3000Dx v regulatory update

Affymetrix said China's State Food and Drug Administration (SFDA) approved its GeneChip System 3000Dx v.2 for in vitro diagnostic use. The company said this is first microarray system approved in China for array-based diagnostics. The...
07:00 , Oct 29, 2007 |  BC Week In Review  |  Company News

Laboratory Corp. of America Holdings, Medco Health Solutions Inc. deal

LH and pharmacy benefit manager MHS partnered to develop a companion diagnostic for tamoxifen, an off-patent selective estrogen receptor modulator (SERM) approved to treat breast cancer. MHS will provide samples from patients given tamoxifen, and...
08:00 , Jan 12, 2005 |  BC Extra  |  Company News

FDA approves Roche's AmpliChip

FDA granted Roche (SWX:ROCZ) 510(k) marketing clearance for the AmpliChip CYP450 test , which analyzes genetic variations in the cytochrome P450 genes 2D6 and 2C19. The test is cleared for use with the GeneChip 3000Dx...
08:00 , Jan 10, 2005 |  BC Week In Review  |  Clinical News

AmpliChip CYP450 Test regulatory update

FDA granted 510(k) marketing clearance for AmpliChip CYP450 test, which analyzes genetic variations in the cytochrome P450 genes 2D6 and 2C19. The test is cleared for use with the GeneChip 3000Dx system from Affymetrix Inc....
08:00 , Nov 8, 2004 |  BC Week In Review  |  Company News

Epidauros, Roche deal

Epidauros granted ROCZ a non-exclusive license to a patent covering a polymorphism of the promoter region of the CYP2D6 gene. ROCZ uses the IP in its AmpliChip CYP450 Test , which is marketed in the...
08:00 , Nov 3, 2004 |  BC Extra  |  Company News

Epidauros, Roche CYP2D6 deal

Epidauros (Bernried, Germany) granted Roche (SWX:ROCZ) a non-exclusive license to a patent covering a polymorphism of the promoter region of the CYP2D6 gene. ROCZ uses the IP in its AmpliChip CYP450 Test , which is...
07:00 , Sep 6, 2004 |  BC Week In Review  |  Clinical News

AmpliChip CYP450 Test regulatory update

ROCZ received CE mark approval for its AmpliChip CYP450 test, which analyzes genetic variations in the cytochrome P450 genes 2D6 and 2C19. The diagnostic test uses Affymetrix Inc. (AFFX, Santa Clara, Calif.) microarrays. Roche (SWX:ROCZ),...